Jianmin Chen

Aug 1, 2023 | mdpi.com | Xiaohong Wu |Jia Li |Lei Zhou |Jianmin Chen

Abstract:Objective: In this paper, we aim to show that the immunogenicity of the lyophilized human rabies vaccine (Vero cells) (investigational vaccine) developed by Dalian Aleph Biomedical Co., Ltd. in healthy participants aged 10–60 years old is non-inferior to the lyophilized PVRV (positive control) manufactured by Liaoning Chengda Biotechnology Co., Ltd. (Shenyang, China), and that its safety is clinically acceptable.

Jul 26, 2023 | nature.com | Rong Wang |Katsumasa Tanaka |Philippe Ciais |Josep Peñuelas |Jordi Sardans |Jianmin Chen | +1 more

AbstractChina’s goal to achieve carbon (C) neutrality by 2060 requires scaling up photovoltaic (PV) and wind power from 1 to 10–15 PWh year−1 (refs. 1,2,3,4,5). Following the historical rates of renewable installation1, a recent high-resolution energy-system model6 and forecasts based on China’s 14th Five-year Energy Development (CFED)7, however, only indicate that the capacity will reach 5–9.5 PWh year−1 by 2060.